Literature DB >> 20171699

Intussusception vasoepididymostomy with longitudinal suture placement for idiopathic obstructive azoospermia.

Rajeev Kumar1, Satyadip Mukherjee, Narmada P Gupta.   

Abstract

PURPOSE: Surgical reconstruction is an important treatment option for obstructive azoospermia. Vasoepididymostomy results have primarily been described in men with previous vasectomy. We evaluated vaso-epididymal anastomosis outcomes using a 2-suture microsurgical intussusception technique with longitudinal suture placement in men with idiopathic obstructive azoospermia.
MATERIALS AND METHODS: Between April 2007 and May 2009, 24 men with idiopathic obstructive azoospermia underwent 2-layer vaso-epididymal anastomosis using a 2-suture intussusception technique. Two double armed 10-zero polyamide sutures were placed parallel to each other longitudinally along the epididymal tubule to intussuscept the tubule into the lumen of the vas deferens for the inner layer of the anastomosis. Patency was assessed by return of sperm in the semen.
RESULTS: A total of 23 men with a mean age of 31 years provided at least 1 postoperative semen sample. All had a mean 67-month history of primary infertility. In 11 men (48%) patency was noted a mean of 6.6 months (range 3 to 15) after surgery. One patient reported pregnancy by natural conception. Men with motile sperm in the epididymal fluid and those with bilateral surgery were more likely to have a patent anastomosis.
CONCLUSIONS: Within 1 year after surgery approximately half of the men who underwent longitudinal vaso-epididymal anastomosis for idiopathic azoospermia had return of sperm in the ejaculate. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171699     DOI: 10.1016/j.juro.2009.12.027

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Surgical techniques for the management of male infertility.

Authors:  Natalya A Lopushnyan; Thomas J Walsh
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

2.  High-frequency ultrasound findings in epididymal malformations.

Authors:  Ensheng Xue; Shun Chen; Rongxi Liang; Xiaodong Lin; Jingjing Guo; Mei Huang
Journal:  J Med Ultrason (2001)       Date:  2013-07-17       Impact factor: 1.314

Review 3.  The evolution and refinement of vasoepididymostomy techniques.

Authors:  Peter T Chan
Journal:  Asian J Androl       Date:  2012-11-19       Impact factor: 3.285

4.  A modified single-armed technique for microsurgical vasoepididymostomy.

Authors:  Liang Zhao; Chun-Hua Deng; Xiang-Zhou Sun; Yu Chen; Wen-Wei Wang; Liang-Yun Zhao; Ling-You Zeng; Xiang-An Tu
Journal:  Asian J Androl       Date:  2012-10-08       Impact factor: 3.285

5.  Two-suture single-armed longitudinal intussusception vasoepididymostomy for obstructive azoospermia: report of patients characteristics and outcome.

Authors:  Saleh Binsaleh
Journal:  Int Urol Nephrol       Date:  2014-09-14       Impact factor: 2.370

6.  "4 × 4 vasovasostomy": A simplified technique for vasectomy reversal.

Authors:  Rajeev Kumar; Satyadip Mukherjee
Journal:  Indian J Urol       Date:  2010-07

7.  Herbo-mineral supplementation in men with idiopathic oligoasthenoteratospermia : A double blind randomized placebo-controlled trial.

Authors:  Rajeev Kumar; Vaibhav Saxena; Monis Bilal Shamsi; S Venkatesh; Rima Dada
Journal:  Indian J Urol       Date:  2011-07

8.  Surgery for azoospermia in the Indian patient: Why is it different?

Authors:  Rajeev Kumar
Journal:  Indian J Urol       Date:  2011-01

9.  Discordant clinical and histological findings predict failure of reconstruction in suspected obstructive azoospermia.

Authors:  Shailesh C Sahay; Venkateswaran K Iyer; Rajeev Kumar
Journal:  Indian J Urol       Date:  2012-01

10.  Advances in surgical treatment of male infertility.

Authors:  Hyo Serk Lee; Ju Tae Seo
Journal:  World J Mens Health       Date:  2012-08-31       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.